Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders

被引:33
作者
Saini, R. [1 ,2 ]
Poh, C. F. [1 ,2 ]
机构
[1] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada
[2] Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
topical; photodynamic therapy; oral potentially malignant disorders; oral dysplasia; TOPICAL 5-AMINOLEVULINIC ACID; INDUCED PROTOPORPHYRIN IX; SQUAMOUS-CELL CARCINOMA; LIGHT-EMITTING DIODE; IN-VIVO; VERRUCOUS HYPERPLASIA; PREMALIGNANT LESIONS; FOLLOW-UP; ENDOGENOUS PROTOPORPHYRIN; PHOTORADIATION THERAPY;
D O I
10.1111/odi.12003
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
With the unreliability of epithelial dysplasia as a predictor to determine the risk of future malignant development, subjectivity associated in evaluating dysplasia by pathologists and paucity of biomarkers that could accurately predict the progression risks in oral potentially malignant disorders (PMDs), eradication of the lesions appears to be the most desirable approach to minimize the risk of invasive cancer formation. Interventions, such as surgery and chemoprevention, have not shown promising long-term results in the treatment of these lesions, and lack of guidelines and general consensus on their management has incited much anxiety and doubts in both patients and community clinicians. Topical photodynamic therapy (PDT) is a minimally invasive and minimally toxic technique that in recent years has shown great promise in the management of PMDs. In this review, we describe the historical developments in the field of PDT, its basic mechanisms, as well as related clinical studies, and its challenges in the management of oral PMDs. Based on its high efficacy and low side effects, its high patient acceptance/compliance, the simplicity of the procedure and its minimal pretreatment preparation, topical PDT is believed to have potential to play an important role in the management of PMDs, especially of the low-grade dysplasia.
引用
收藏
页码:440 / 451
页数:12
相关论文
共 146 条
  • [31] DOUGHERTY TJ, 1978, CANCER RES, V38, P2628
  • [32] Eguchi Y, 1997, CANCER RES, V57, P1835
  • [33] ALA and Photofrin® fluorescence-guided resection and repetitive PDT in glioblastoma multiforme:: a single centre Phase III randomised controlled trial
    Eljamel, M. Sam
    Goodman, Carol
    Moseley, Harry
    [J]. LASERS IN MEDICAL SCIENCE, 2008, 23 (04) : 361 - 367
  • [34] Epstein JB, 1998, CANCER-AM CANCER SOC, V83, P629, DOI 10.1002/(SICI)1097-0142(19980815)83:4<629::AID-CNCR1>3.0.CO
  • [35] 2-F
  • [36] Epstein JB, 1999, CANCER-AM CANCER SOC, V86, P921, DOI 10.1002/(SICI)1097-0142(19990915)86:6<921::AID-CNCR5>3.0.CO
  • [37] 2-6
  • [38] Fan KFM, 1997, INT J CANCER, V73, P25
  • [39] Fan KFM, 1996, CANCER-AM CANCER SOC, V78, P1374
  • [40] Ferlay J., 2010, GLOBOCAN 2008 CANC I